• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子-β1在系统性硬化症、特发性肺纤维化及其他肺部疾病患者肺组织中的免疫组化定位

Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.

作者信息

Corrin B, Butcher D, McAnulty B J, Dubois R M, Black C M, Laurent G J, Harrison N K

机构信息

Department of Pathology, National Heart and Lung Institute, Royal Brompton Hospital, London, UK.

出版信息

Histopathology. 1994 Feb;24(2):145-50. doi: 10.1111/j.1365-2559.1994.tb01293.x.

DOI:10.1111/j.1365-2559.1994.tb01293.x
PMID:8181807
Abstract

To study the role of transforming growth factor-beta 1 (TGF-beta 1) in the pathogenesis of pulmonary fibrosis we have examined lung biopsies from nine patients with systemic sclerosis and interstitial lung disease, eight with 'lone' cryptogenic fibrosing alveolitis, two with cystic fibrosis, two with extrinsic allergic alveolitis, two with Langerhans' cell histiocytosis, one with lymphangioleiomyomatosis, one with giant cell interstitial pneumonia, and one adenocarcinoma of the lung. In cryptogenic fibrosing alveolitis, both 'lone' and associated with systemic sclerosis alveolar macrophages, bronchial epithelium and hyperplastic type II pneumonocytes expressed intracellular TGF-beta 1. Extracellular TGF-beta 1 was found in the fibrous tissue immediately beneath the bronchial and hyperplastic alveolar epithelium. In normal lung, however, the alveolar epithelium and alveolar interstitium were negative for both forms of TGF-beta 1. There was strong expression of TGF-beta 1 in hyperplastic mesothelium and its underlying connective tissue and in Langerhans' cells in the two cases of histiocytosis. In the organizing pneumonia in cystic fibrosis, the intraalveolar buds of granulation tissue reacted strongly for the extracellular form of TGF-beta 1 and the overlying hyperplastic epithelium expressed the intracellular form. In lymphangioleiomyomatosis, the aberrant smooth muscle cells strongly expressed intracellular TGF-beta 1 and the extracellular form was expressed in the adjacent connective tissue. In giant cell interstitial pneumonia, the numerous alveolar macrophage including the multinucleate forms, expressed intracellular TGF-beta 1, as did the hyperplastic alveolar epithelium.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为研究转化生长因子β1(TGF-β1)在肺纤维化发病机制中的作用,我们检测了9例系统性硬化症合并间质性肺病患者、8例“特发性”隐源性纤维性肺泡炎患者、2例囊性纤维化患者、2例外源性过敏性肺泡炎患者、2例朗格汉斯细胞组织细胞增多症患者、1例淋巴管平滑肌瘤病患者、1例巨细胞间质性肺炎患者及1例肺腺癌患者的肺活检标本。在隐源性纤维性肺泡炎中,无论是“特发性”还是合并系统性硬化症的病例,肺泡巨噬细胞、支气管上皮及增生的II型肺上皮细胞均表达细胞内TGF-β1。在支气管及增生的肺泡上皮下方的纤维组织中发现细胞外TGF-β1。然而,在正常肺组织中,肺泡上皮及肺泡间质的两种形式的TGF-β1均为阴性。在两例组织细胞增多症中,增生的间皮及其下方的结缔组织以及朗格汉斯细胞中TGF-β1表达强烈。在囊性纤维化的机化性肺炎中,肺泡内肉芽组织芽对细胞外形式的TGF-β1反应强烈,其上方增生的上皮表达细胞内形式。在淋巴管平滑肌瘤病中,异常的平滑肌细胞强烈表达细胞内TGF-β1,细胞外形式在相邻结缔组织中表达。在巨细胞间质性肺炎中,众多肺泡巨噬细胞包括多核巨噬细胞表达细胞内TGF-β1,增生的肺泡上皮也如此。(摘要截于250词)

相似文献

1
Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders.转化生长因子-β1在系统性硬化症、特发性肺纤维化及其他肺部疾病患者肺组织中的免疫组化定位
Histopathology. 1994 Feb;24(2):145-50. doi: 10.1111/j.1365-2559.1994.tb01293.x.
2
Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.隐源性纤维性肺泡炎和与系统性硬化症相关的纤维性肺泡炎中不同的细胞因子谱:开放性肺活检的定量研究。
Eur Respir J. 1999 Aug;14(2):251-7. doi: 10.1034/j.1399-3003.1999.14b03.x.
3
Structural features of interstitial lung disease in systemic sclerosis.
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):706-13. doi: 10.1164/ajrccm/144.3_Pt_1.706.
4
Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Eur Respir J. 1995 Feb;8(2):266-71. doi: 10.1183/09031936.95.08020266.
5
Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis.肿瘤坏死因子-α在隐源性纤维性肺泡炎中的表达
Histopathology. 1993 Apr;22(4):343-7. doi: 10.1111/j.1365-2559.1993.tb00133.x.
6
TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study.转化生长因子-β1,而非转化生长因子-β2或转化生长因子-β3,在晚期肺纤维化上皮细胞中呈差异表达:一项免疫组织化学研究。
Am J Respir Cell Mol Biol. 1996 Feb;14(2):131-8. doi: 10.1165/ajrcmb.14.2.8630262.
7
Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer.转化生长因子-β1在实验性矽肺、II型肺泡上皮细胞增生及肺癌大鼠中的免疫组织化学定位
Am J Pathol. 1993 Jun;142(6):1831-40.
8
Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis.肺纤维化中富含半胱氨酸的酸性分泌蛋白(SPARC)、肌腱蛋白和血小板反应蛋白的免疫定位
Am J Pathol. 1995 Dec;147(6):1759-69.
9
[Different cytokine profiles in usual interstitial pneumonia and nonspecific interstitial pneumonia].[寻常型间质性肺炎和非特异性间质性肺炎中不同的细胞因子谱]
Zhonghua Jie He He Hu Xi Za Zhi. 2003 Jun;26(6):350-3.
10
Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis.转化生长因子-β1在肺结节病非坏死性肉芽肿中的免疫组织化学定位
Am J Respir Crit Care Med. 1994 Jan;149(1):197-204. doi: 10.1164/ajrccm.149.1.8111583.

引用本文的文献

1
TGF-β signaling in health, disease, and therapeutics.TGF-β 信号在健康、疾病和治疗中的作用。
Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w.
2
Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives.硬皮病间质性肺疾病中的肺泡上皮-间充质转化:技术挑战、现有证据及治疗前景
J Scleroderma Relat Disord. 2024 Feb;9(1):7-15. doi: 10.1177/23971983231181727. Epub 2023 Jun 20.
3
Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
增强内源性骨形态发生蛋白信号传导可预防博来霉素诱导的肺纤维化。
Respir Res. 2015 Mar 15;16(1):38. doi: 10.1186/s12931-015-0202-x.
4
Current and novel drug therapies for idiopathic pulmonary fibrosis.特发性肺纤维化的现有及新型药物疗法
Drug Des Devel Ther. 2012;6:261-72. doi: 10.2147/DDDT.S29928. Epub 2012 Sep 26.
5
Getting out of a sticky situation: targeting the myofibroblast in scleroderma.摆脱棘手困境:靶向硬皮病中的肌成纤维细胞
Open Rheumatol J. 2012;6:163-9. doi: 10.2174/1874312901206010163. Epub 2012 Jun 15.
6
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia.特发性非特异性间质性肺炎中的重度肺动脉高压。
Pulm Circ. 2012 Jan-Mar;2(1):101-6. doi: 10.4103/2045-8932.94842.
7
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease.甲磺酸伊马替尼治疗系统性硬化症相关活动性间质性肺病的为期一年的I/IIa期开放标签试点试验。
Arthritis Rheum. 2011 Nov;63(11):3540-6. doi: 10.1002/art.30548.
8
Cyclophosphamide for scleroderma lung disease: a systematic review and meta-analysis.环磷酰胺治疗硬皮病肺疾病:系统评价和荟萃分析。
Rheumatol Int. 2012 Aug;32(8):2431-44. doi: 10.1007/s00296-011-1967-y. Epub 2011 Jun 21.
9
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.系统性硬化症相关间质性肺疾病:来自临床试验、结局指标及未来研究设计的经验教训
Curr Rheumatol Rev. 2010 May 1;6(2):138-144. doi: 10.2174/157339710791330768.
10
Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens.囊性纤维化遗传修饰物与先天性双侧输精管缺如的关联。
Fertil Steril. 2010 Nov;94(6):2122-7. doi: 10.1016/j.fertnstert.2009.11.044. Epub 2010 Jan 25.